Received Feb 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | YE232 | IM / LA |
No adverse effects but patient already had dose of arexvy 10/2024 unknown at time that patient had previously received a dose
no
raloxifene
PCN